Ocular toxicity of fluoroquinolones

Donohoo E, 2005, Mims New Ethicals

Mehta DK, 2006, British National Formulary.

Thomas J, 2006, Australian Prescription Products Guide.

PDR Staff, 2005, Physicians' Desk Reference

Weisbecker CA, 2001, Physician's Desk Reference for Ophthalmic Medicines

10.1093/oxfordjournals.jac.a020889

10.1016/S0025-7125(05)70297-2

10.2165/00003495-199500492-00005

10.1016/S0924-8579(00)00192-8

Ogawa GSH, 1997, Textbook of Ocular Pharmacology., 537

10.1016/j.survophthal.2005.07.001

10.1016/S0002-9394(02)01334-X

10.2165/00003495-199958002-00003

10.1111/j.1365-2885.1996.tb00001.x

10.2165/00003495-199958002-00002

10.2165/00003495-199958002-00006

Neu HC, 1988, Quinolones: a new class of antimicrobial agents with wide potential uses, Med Clin North Am, 72, 623, 10.1016/S0025-7125(16)30762-3

10.1034/j.1600-0420.1998.760610.x

10.1016/S0378-5173(00)00482-8

10.1136/bjo.83.10.1183

10.1001/archopht.1997.01100150175004

10.1016/S0161-6420(13)31248-2

10.1016/S0002-9394(14)73019-3

10.1016/S0002-9394(14)71460-6

10.1016/S0161-6420(99)90527-4

10.1016/j.jcrs.2004.06.048

Huber‐Spitzy VN, 1992, Penetration of norfloxacin into the aqueous humor of the human eye, Invest Ophthalmol Vis Sci, 33, 1723

10.1136/bjo.78.7.546

10.1016/S0161-6420(13)31672-8

10.1016/j.ophtha.2006.01.061

10.1016/S0378-5173(00)00483-X

Kaplan HJ, 1992, Vitreous levels of ciprofloxacin after intravitreal injection in the rabbit, Invest Ophthalmol Vis Sci, 33, 729

10.1136/bjo.84.9.1061

10.1038/eye.1999.137

10.1128/AAC.39.2.549

10.1211/0022357991773168

10.1211/0022357991773159

10.1016/j.jcrs.2004.12.063

10.1016/S0149-2918(00)80053-3

10.1086/515104

10.1097/00004397-199303340-00007

10.1016/S0161-6420(96)30416-8

10.1001/archopht.1993.01090090062020

Leibowitz HM, 1991, Clinical evaluation of ciprofloxacin 0.3% ophthalmic solution for treatment of bacterial keratitis, Am J Ophthalmol, 112, S34

Tripathi A, 2002, Acute psychosis following the use of topical ciprofloxacin, Arch Ophthalmol, 120, 665

10.1016/S0161-6420(91)32329-7

10.1016/S0161-6420(90)32518-6

10.1046/j.1365-2125.1996.03013.x

10.2165/00002018-200022060-00006

10.3109/00365599709030647

10.1097/00000441-199602000-00005

10.2169/internalmedicine.34.872

10.1136/bmj.299.6700.658

Zabraniecki L, 1996, Fluoroquinolone induced tendinopathy: report of 6 cases, J Rheumatol, 23, 516

Ribard P, 1992, Seven Achilles tendinitis including 3 complicated by rupture during fluoroquinolone therapy, J Rheumatol, 19, 1479

10.1002/1529-0131(200106)45:3<235::AID-ART254>3.0.CO;2-7

10.1177/107110079701800510

10.1016/S0140-6736(88)92489-0

Bailey RR, 1983, Norfloxacin‐induced rheumatic disease, NZ Med J, 96, 590

10.1093/clinids/18.6.946

10.1016/S0378-4274(01)00509-4

10.1038/eye.1992.23

10.1136/bjo.76.12.714

10.1001/archopht.1992.01080210052022

10.1016/S0002-9394(00)00642-5

10.1136/bjo.84.4.378

10.1006/taap.1999.8653

[No authors listed]., 1999, Quinolones and pregnancy: worrying animal findings, few clinical data, Prescrire Int, 8, 29

Altreuther P, 1987, Data on chemistry and toxicology of Baytril, Vet Med Rev, 2, 87

10.1016/S1383-5718(01)00275-3

Guzman A, 2003, Developmental toxicity studies of the quinolone antibacterial agent irloxacin in rats and rabbits, Arzneimittelforschung, 53, 121

10.1002/jat.1033

10.1007/s002040050662

10.1007/s002040000162

10.1093/jac/33.4.685

10.1016/S0378-4274(98)00378-6

10.1046/j.1432-1327.1998.2520001.x

10.1006/abbi.1997.0124

10.1046/j.1523-1747.2003.12422.x

10.1016/S0887-2333(02)00029-2

10.1016/S1011-1344(00)00101-9

10.1006/faat.1996.0084

10.1007/s002040100263

10.3109/02713688408997182

10.1159/000267500

10.1128/AAC.42.7.1831

10.1128/AAC.41.11.2389

10.1136/bmj.324.7349.1306

10.1177/019262339502300315

10.1007/s002040000203

10.1128/AAC.44.2.261-266.2000

10.1128/AAC.39.9.1979

10.1007/s002040100243

10.1042/CS20000073

10.1002/art.10617

10.1128/AAC.44.4.867-872.2000

10.1093/rheumatology/keg372

10.1097/01.ico.0000154233.56736.08

10.1016/S0886-3350(01)00893-8

10.1016/S0002-9394(99)80104-4

10.1097/00003226-199707000-00008

10.1097/00003226-199507000-00009

10.1016/S0002-9394(14)73086-7

10.3109/02713689109001764

10.1097/00003226-200307000-00014

10.1001/archopht.1991.01080120121040

Bekoe NA, 1999, Effects of ciprofloxacin, ofloxacin, and gentamicin on corneal cells and wound healing [ARVO abstract], Invest Ophthalmol Vis Sci, 40, B770

10.1097/00003226-199703000-00014

10.1097/00003226-199803000-00012

Rootman DS, 1992, Toxicity and pharmacokinetics of intravitreally injected ciprofloxacin in rabbit eyes, Can J Ophthalmol, 27, 277

10.3109/02713689109003447

10.1159/000027404

10.1023/A:1006137100444

10.1089/jop.1997.13.369

10.1076/ceyr.27.6.387.18192

10.1167/iovs.05-1124

10.1167/iovs.05-0702

10.1097/00006982-200602000-00011

10.1046/j.1442-9071.2000.00256.x

10.1128/AAC.39.7.1493